Table 2.
Characteristics of 90 black NEPTUNE subjects
| Characteristic | LR (n=51) | HR (n=39) | P Value |
|---|---|---|---|
| Age (y) | 17.0 (12.0–46.5) | 17.0 (14.5–32.5) | 0.80 |
| Pediatric | 27 (53) | 21 (54) | 1.00 |
| Age of onset (y) | 15.5 (10.0–40.8) | 17.0 (14.0–28.2) | 0.60 |
| Duration disease (y) | 1.0 (0.0–3.0) | 0.0 (0.0–1.8) | 0.40 |
| Male | 32 (63) | 25 (64) | 1.00 |
| Histopath | <0.01 | ||
| FSGS | 17 (33) | 25 (64) | |
| MCD | 15 (29) | 5 (13) | |
| MN | 10 (20) | 1 (3) | |
| Other | 9 (18) | 8 (21) | |
| Clinical characteristics at baseline | |||
| RAAS blockade | 14 (27) | 11 (28) | 1.00 |
| eGFR | 83.7 (65.8–105.6) | 67.2 (42.9–84.5) | 0.02 |
| UPC | 2.9 (1.9–7.2) | 3.1 (1.3–6.9) | 0.94 |
Data presented as median (interquartile range) for quantitative variables and as count (%) for categorical characteristics. The P values were determined using Wilcoxon rank-sum test or Fisher’s exact test. Age, patient age at enrollment; Other, other glomerulopathies.